DAVITA INC (DVA) Fundamental Analysis & Valuation

NYSE:DVA • US23918K1088

Current stock price

151.65 USD
-3.49 (-2.25%)
At close:
151.65 USD
0 (0%)
After Hours:

This DVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. DVA Profitability Analysis

1.1 Basic Checks

  • DVA had positive earnings in the past year.
  • In the past year DVA had a positive cash flow from operations.
  • Each year in the past 5 years DVA has been profitable.
  • In the past 5 years DVA always reported a positive cash flow from operatings.
DVA Yearly Net Income VS EBIT VS OCF VS FCFDVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.27%, DVA is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 11.22%, DVA belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for DVA is in line with the industry average of 8.40%.
  • The last Return On Invested Capital (11.22%) for DVA is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROIC 11.22%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
DVA Yearly ROA, ROE, ROICDVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600

1.3 Margins

  • DVA has a Profit Margin of 5.47%. This is amongst the best in the industry. DVA outperforms 81.00% of its industry peers.
  • In the last couple of years the Profit Margin of DVA has declined.
  • DVA's Operating Margin of 14.74% is amongst the best of the industry. DVA outperforms 91.00% of its industry peers.
  • DVA's Operating Margin has been stable in the last couple of years.
  • DVA has a better Gross Margin (32.25%) than 64.00% of its industry peers.
  • DVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
DVA Yearly Profit, Operating, Gross MarginsDVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DVA Health Analysis

2.1 Basic Checks

  • DVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DVA has less shares outstanding than it did 1 year ago.
  • DVA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DVA has a worse debt to assets ratio.
DVA Yearly Shares OutstandingDVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
DVA Yearly Total Debt VS Total AssetsDVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that DVA is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.54, DVA is not doing good in the industry: 61.00% of the companies in the same industry are doing better.
  • DVA has a debt to FCF ratio of 7.84. This is a slightly negative value and a sign of low solvency as DVA would need 7.84 years to pay back of all of its debts.
  • DVA has a Debt to FCF ratio (7.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Altman-Z 1.54
ROIC/WACC1.34
WACC8.38%
DVA Yearly LT Debt VS Equity VS FCFDVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • DVA has a Current Ratio of 1.29. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
  • DVA has a Current ratio (1.29) which is in line with its industry peers.
  • DVA has a Quick Ratio of 1.24. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
  • DVA's Quick ratio of 1.24 is in line compared to the rest of the industry. DVA outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.24
DVA Yearly Current Assets VS Current LiabilitesDVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DVA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.37% over the past year.
  • DVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.46% yearly.
  • Looking at the last year, DVA shows a small growth in Revenue. The Revenue has grown by 6.46% in the last year.
  • DVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.56% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y35.91%
EPS Next 2Y25.99%
EPS Next 3Y21.89%
EPS Next 5Y20.56%
Revenue Next Year3.8%
Revenue Next 2Y3.44%
Revenue Next 3Y3.68%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DVA Yearly Revenue VS EstimatesDVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
DVA Yearly EPS VS EstimatesDVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

8

4. DVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.60, which indicates a correct valuation of DVA.
  • Compared to the rest of the industry, the Price/Earnings ratio of DVA indicates a rather cheap valuation: DVA is cheaper than 83.00% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of DVA to the average of the S&P500 Index (26.64), we can say DVA is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 10.74 indicates a reasonable valuation of DVA.
  • 86.00% of the companies in the same industry are more expensive than DVA, based on the Price/Forward Earnings ratio.
  • DVA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.6
Fwd PE 10.74
DVA Price Earnings VS Forward Price EarningsDVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DVA indicates a rather cheap valuation: DVA is cheaper than 85.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, DVA is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.73
EV/EBITDA 7.3
DVA Per share dataDVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200

4.3 Compensation for Growth

  • DVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of DVA may justify a higher PE ratio.
  • DVA's earnings are expected to grow with 21.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)1.96
EPS Next 2Y25.99%
EPS Next 3Y21.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DVA Dividend Analysis

5.1 Amount

  • No dividends for DVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DVA Fundamentals: All Metrics, Ratios and Statistics

DAVITA INC

NYSE:DVA (5/1/2026, 8:22:30 PM)

After market: 151.65 0 (0%)

151.65

-3.49 (-2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)02-02
Earnings (Next)05-05
Inst Owners52.84%
Inst Owner Change-0.06%
Ins Owners5.1%
Ins Owner Change2.45%
Market Cap10.13B
Revenue(TTM)13.64B
Net Income(TTM)746.80M
Analysts68.57
Price Target154.54 (1.91%)
Short Float %17.87%
Short Ratio7.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.32%
Min EPS beat(2)-37.31%
Max EPS beat(2)6.68%
EPS beat(4)3
Avg EPS beat(4)-6.2%
Min EPS beat(4)-37.31%
Max EPS beat(4)6.68%
EPS beat(8)5
Avg EPS beat(8)-2.1%
EPS beat(12)9
Avg EPS beat(12)2.69%
EPS beat(16)10
Avg EPS beat(16)-2.86%
Revenue beat(2)1
Avg Revenue beat(2)0.63%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.49%
Revenue beat(4)1
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)2.49%
Revenue beat(8)3
Avg Revenue beat(8)0.05%
Revenue beat(12)7
Avg Revenue beat(12)0.59%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)10.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.99%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)10.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 14.6
Fwd PE 10.74
P/S 0.74
P/FCF 7.73
P/OCF 5.37
P/B N/A
P/tB N/A
EV/EBITDA 7.3
EPS(TTM)10.39
EY6.85%
EPS(NY)14.12
Fwd EY9.31%
FCF(TTM)19.62
FCFY12.94%
OCF(TTM)28.24
OCFY18.62%
SpS204.24
BVpS-9.75
TBVpS-126.02
PEG (NY)0.41
PEG (5Y)1.96
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 4.27%
ROE N/A
ROCE 14.02%
ROIC 11.22%
ROICexc 11.79%
ROICexgc 27.39%
OM 14.74%
PM (TTM) 5.47%
GM 32.25%
FCFM 9.61%
ROA(3y)4.59%
ROA(5y)4.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)9.62%
ROICexc(3y)10.88%
ROICexc(5y)10.02%
ROICexgc(3y)24.5%
ROICexgc(5y)21.86%
ROCE(3y)12.97%
ROCE(5y)12.02%
ROICexgc growth 3Y20.64%
ROICexgc growth 5Y7.57%
ROICexc growth 3Y16.27%
ROICexc growth 5Y4.4%
OM growth 3Y9.25%
OM growth 5Y0.22%
PM growth 3Y4.31%
PM growth 5Y-3.96%
GM growth 3Y3.26%
GM growth 5Y0.9%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.84
Debt/EBITDA 3.73
Cap/Depr 80.5%
Cap/Sales 4.22%
Interest Coverage 3.9
Cash Conversion 69.2%
Profit Quality 175.5%
Current Ratio 1.29
Quick Ratio 1.24
Altman-Z 1.54
F-Score6
WACC8.38%
ROIC/WACC1.34
Cap/Depr(3y)77.81%
Cap/Depr(5y)82.01%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.79%
Profit Quality(3y)182.58%
Profit Quality(5y)170.25%
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y22.66%
EPS 5Y7.46%
EPS Q2Q%51.79%
EPS Next Y35.91%
EPS Next 2Y25.99%
EPS Next 3Y21.89%
EPS Next 5Y20.56%
Revenue 1Y (TTM)6.46%
Revenue growth 3Y5.53%
Revenue growth 5Y3.39%
Sales Q2Q%9.87%
Revenue Next Year3.8%
Revenue Next 2Y3.44%
Revenue Next 3Y3.68%
Revenue Next 5Y5.41%
EBIT growth 1Y2.85%
EBIT growth 3Y15.29%
EBIT growth 5Y3.61%
EBIT Next Year39.73%
EBIT Next 3Y14.35%
EBIT Next 5Y12.19%
FCF growth 1Y-10.63%
FCF growth 3Y10.89%
FCF growth 5Y0.09%
OCF growth 1Y-6.7%
OCF growth 3Y6.44%
OCF growth 5Y-0.95%

DAVITA INC / DVA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DAVITA INC (DVA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DVA.


What is the valuation status for DVA stock?

ChartMill assigns a valuation rating of 8 / 10 to DAVITA INC (DVA). This can be considered as Undervalued.


What is the profitability of DVA stock?

DAVITA INC (DVA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of DAVITA INC (DVA) stock?

The Price/Earnings (PE) ratio for DAVITA INC (DVA) is 14.6 and the Price/Book (PB) ratio is -15.56.


What is the expected EPS growth for DAVITA INC (DVA) stock?

The Earnings per Share (EPS) of DAVITA INC (DVA) is expected to grow by 35.91% in the next year.